澳大利亚骨关节炎与类风湿关节炎至2030年的疾病负担预测
该研究基于澳大利亚统计局2014-2015年全国健康调查的患病率数据与人口预测,构建流行病学模型,预测2020、2025和2030年骨关节炎(OA)和类风湿关节炎(RA)的患病人数及直接医疗费用。
要点
- RA患病人数预计从2015年422,309人增至2030年579,915人。
核心结论
- OA和RA是费用高昂的疾病,将在人群层面造成日益增加的医疗负担。
- 这些预测为规划未来医疗服务供给以匹配预期需求提供了具体数据。
研究设计与样本
- 开发了澳大利亚人口的流行病学模型,基于澳大利亚统计局(ABS)2014-2015年全国健康调查的OA和RA全国患病率数据。
- 使用ABS对2020、2025和2030年的人口预测估计未来患病率,并从澳大利亚公共卫生系统角度建模政府直接医疗支出数据以预测费用。
主要发现
- RA患病人数预计从2015年422,309人增至2030年579,915人。
关键数值与推荐
- RA患病人数:2015年422,309人,2030年579,915人。
临床怎么用
- 预测数据可用于规划未来医疗服务供给以匹配OA和RA的预期需求。
- 提示需关注RA生物改善病情抗风湿药费用在总医疗支出中的占比。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To forecast the prevalence and direct health care costs of osteoarthritis (OA) and rheumatoid arthritis (RA) in Australia to the year 2030. METHODS: An epidemiologic model of the Australian population was developed. Data on the national prevalence of OA and RA were obtained from the Australian Bureau of Statistics (ABS) 2014-2015 National Health Survey. Future prevalence was estimated using ABS population projections for 2020, 2025, and 2030. Available government data on direct health care expenditure for OA and RA were modeled to forecast costs (in Australian $) for the years 2020, 2025, and 2030, from the perspective of the Australian public health care system. RESULTS: The number of people with OA is expected to increase nationally from almost 2.2 million in 2015 to almost 3.1 million Australians in 2030. The number of people with RA is projected to increase from 422,309 in 2015 to 579,915 in 2030. Health care costs for OA were estimated to be over $2.1 billion in 2015; by the year 2030, these are forecast to exceed $2.9 billion ($970 for every person with the condition). Health care costs for RA were estimated to be over $550 million in 2015, including $273 million spent on biologic disease-modifying antirheumatic drugs. Health care costs for RA are projected to rise to over $755 million by the year 2030. CONCLUSION: OA and RA are costly conditions that will impose an increasing health care burden at the population level. These projections provide tangible data that can be used to map future health service provision to expected need.
引用
- Ackerman IN, Pratt C, Gorelik A, et al. Projected Burden of Osteoarthritis and Rheumatoid Arthritis in Australia: A Population-Level Analysis. Arthritis Care Res (Hoboken). 2018. PMID: 28898565. doi:10.1002/acr.23414
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。